​

Fulgent Genetics (FLGT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FLGT Stock Forecast

Fulgent Genetics (FLGT) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $25.00, with a high of $25.00 and a low of $25.00. This represents a 19.10% increase from the last price of $20.99.

$15 $18 $21 $24 $27 $30 High: $25 Avg: $25 Low: $25 Last Closed Price: $20.99

FLGT Stock Rating

Fulgent Genetics stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (62.50%), 3 Hold (37.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 3 5 Strong Sell Sell Hold Buy Strong Buy

FLGT Price Target Upside V Benchmarks

TypeNameUpside
StockFulgent Genetics19.10%
SectorHealthcare Stocks 23.68%
IndustryDiagnostics & Research Stocks22.21%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$25.00$25.00
Last Closing Price$20.99$20.99$20.99
Upside/Downside-19.10%19.10%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 251-2--3
May, 251-2--3
Apr, 251-2--3
Mar, 251-2--3
Feb, 251-2--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 05, 2025Andrew CooperRaymond James$25.00$19.5627.81%19.10%
Dec 08, 2022Piper Sandler$40.00$37.077.90%90.57%
Nov 18, 2022Raymond James$45.00$35.8925.38%114.39%
Nov 14, 2022Credit Suisse$50.00$39.2427.42%138.21%
May 15, 2022David WestenbergPiper Sandler$70.00$54.4528.56%233.49%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 06, 2025Piper SandlerNeutralNeutralhold
May 05, 2025Raymond JamesOutperformOutperformhold
Mar 02, 2025UBSNeutralNeutralhold
Dec 08, 2022Piper SandlerOverweightNeutraldowngrade
Nov 18, 2022Raymond JamesOutperforminitialise
Nov 14, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-10 $-4 $2 $8 $14 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$9.64$17.13$4.76$-5.63$-1.41--
Avg Forecast$6.26$15.68$5.61$-0.98$0.33$-0.15$0.03
High Forecast$6.48$16.23$5.83$-0.91$0.35$0.46$0.03
Low Forecast$6.08$15.24$5.43$-1.05$0.30$-0.77$0.03
Surprise %53.99%9.25%-15.15%474.49%-527.27%--

Revenue Forecast

$250M $400M $550M $700M $850M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$421.71M$992.58M$618.97M$289.21M$283.47M--
Avg Forecast$326.19M$933.03M$610.81M$278.40M$281.98M$324.65M$365.32M
High Forecast$334.97M$958.17M$629.02M$278.43M$284.35M$336.32M$365.59M
Low Forecast$319.09M$912.73M$595.77M$278.35M$279.61M$312.97M$365.05M
Surprise %29.29%6.38%1.34%3.89%0.53%--

Net Income Forecast

$-250M $-80M $90M $260M $430M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$214.31M$507.36M$143.40M$-167.82M$-42.71M--
Avg Forecast$186.38M$460.60M$336.61M$-167.82M$9.55M$-4.58M$784.00K
High Forecast$192.91M$552.73M$403.94M$-134.26M$10.28M$13.75M$820.12K
Low Forecast$181.11M$368.48M$269.29M$-201.39M$8.81M$-22.92M$747.88K
Surprise %14.98%10.15%-57.40%--547.43%--

FLGT Forecast FAQ

Is Fulgent Genetics stock a buy?

Fulgent Genetics stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Fulgent Genetics is a favorable investment for most analysts.

What is Fulgent Genetics's price target?

Fulgent Genetics's price target, set by 8 Wall Street analysts, averages $25 over the next 12 months. The price target range spans from $25 at the low end to $25 at the high end, suggesting a potential 19.10% change from the previous closing price of $20.99.

How does Fulgent Genetics stock forecast compare to its benchmarks?

Fulgent Genetics's stock forecast shows a 19.10% upside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the diagnostics & research stocks industry (22.21%).

What is the breakdown of analyst ratings for Fulgent Genetics over the past three months?

  • June 2025: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Fulgent Genetics’s EPS forecast?

Fulgent Genetics's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.15, marking a -89.36% decrease from the reported $-1.41 in 2024. Estimates for the following years are.

What is Fulgent Genetics’s revenue forecast?

Fulgent Genetics's average annual revenue forecast for its fiscal year ending in December 2025 is $324.65M, reflecting a 14.53% increase from the reported $283.47M in 2024. The forecast for.

What is Fulgent Genetics’s net income forecast?

Fulgent Genetics's net income forecast for the fiscal year ending in December 2025 stands at $-4.585M, representing a -89.26% decrease from the reported $-42.708M in 2024. Projections indicate .